semaglutide fda news The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added 🚨 BIG NEWS for obesity

Weiss, H

Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed

If their BMI is 30-35, they must have certain types of heart failure, hard to control blood or chronic kidney disease

Book Your Skin Consultation with Dr

Hims & Hers Health Inc., an online pharmacy platform founded in 2017, said it would offer compounded GLP-1 drugs with the same active ingredient (semaglutide) as Novo Nordisks mega-blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy, at a significantly lower price of $199 per month

In order to further extend the half-life of GLP-1, the tightness of the binding of GLP-1 drug molecules to HSA needs to be enhanced